EUROPE MEDICAL ENZYMES MARKET FORECAST 2022-2030
TABLE
OF CONTENTS
1. RESEARCH
SCOPE & METHODOLOGY
1.1. STUDY
OBJECTIVES
1.2. SCOPE
OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS
& LIMITATIONS
2. EXECUTIVE
SUMMARY
2.1. MARKET
SIZE & ESTIMATES
2.2. MARKET
OVERVIEW
3. MARKET
DYNAMICS
3.1. KEY DRIVERS
3.1.1. INCREASED
INVESTMENT IN HEALTHCARE RESEARCH AND FACILITIES
3.1.2. WIDENING
APPLICATION IN MEDICAL INDUSTRY
3.1.3. GROWING
PREVALENCE OF CHRONIC DISEASES AND RISING AGING POPULATION
3.2. KEY
RESTRAINTS
3.2.1. HANDLING
AND SAFETY OF ENZYMES
3.2.2. REGULATIONS
FOR MEDICAL ENZYMES
4. KEY
ANALYTICS
4.1. IMPACT
OF COVID-19 ON MEDICAL ENZYMES MARKET
4.2. KEY
MARKET TRENDS
4.3. PORTER’S
FIVE FORCES ANALYSIS
4.3.1. BUYERS
POWER
4.3.2. SUPPLIERS
POWER
4.3.3. SUBSTITUTION
4.3.4. NEW
ENTRANTS
4.3.5. INDUSTRY
RIVALRY
4.4. OPPORTUNITY
MATRIX
4.5. VENDOR
LANDSCAPE
4.6. VALUE
CHAIN ANALYSIS
4.6.1. RESEARCH
AND DEVELOPMENT
4.6.2. OPERATIONS
4.6.3. OUTBOUND
LOGISTICS
4.7. KEY
BUYING CRITERIA
4.7.1. COST
4.7.2. QUALITY
4.7.3. APPLICATION
4.8. REGULATORY
FRAMEWORK
5. MARKET
BY TYPE
5.1. HYDROLASE
5.1.1. HYALURONIDASE
5.1.2. LYSOZYMES
5.1.3. OTHER
HYDROLASES ENZYMES
5.2. THROMBOLYTIC
5.2.1. STREPTOKINASE
5.2.2. UROKINASE
5.2.3. OTHER
THROMBOLYTIC ENZYMES
5.3. DIGESTIVE
ENZYME
5.3.1. LACTASE
5.3.2. L-ASPARAGINASE
5.3.3. OTHER
DIGESTIVE ENZYMES
5.4. ENDONUCLEASE
5.4.1. BENZONASE
5.4.2. OTHER
ENDONUCLEASES
6. MARKET
BY APPLICATION
6.1. DISEASE
TREATMENT
6.2. DIAGNOSTIC
TOOLS
6.3. BIOMEDICAL
RESEARCH
6.4. OTHER
APPLICATIONS
7. GEOGRAPHICAL
ANALYSIS
7.1. EUROPE
7.1.1. MARKET
SIZE & ESTIMATES
7.1.2. KEY
GROWTH ENABLERS
7.1.3. KEY
CHALLENGES
7.1.4. KEY
PLAYERS
7.1.5. COUNTRY
ANALYSIS
7.1.5.1. UNITED
KINGDOM
7.1.5.2. GERMANY
7.1.5.3. FRANCE
7.1.5.4. ITALY
7.1.5.5. BELGIUM
7.1.5.6. POLAND
7.1.5.7. REST
OF EUROPE
8. COMPETITIVE
LANDSCAPE
8.1. KEY
STRATEGIC DEVELOPMENTS
8.1.1. MERGERS
& ACQUISITIONS
8.1.2. PRODUCT
LAUNCHES & DEVELOPMENTS
8.1.3. PARTNERSHIPS
& AGREEMENTS
8.1.4. BUSINESS
EXPANSIONS & DIVESTITURES
8.2. COMPANY
PROFILES
8.2.1. ADVANCED
ENZYMES
8.2.2. AMANO
ENZYME
8.2.3. BASF
8.2.4. BBI
SOLUTIONS
8.2.5. BRAIN
8.2.6. CODEXIS
8.2.7. CPC
BIOTECH
8.2.8. DSM
8.2.9. DUPONT
8.2.10. NOVOZYMES
8.2.11. NOVUS
8.2.12. ROCHE
8.2.13. SANOFI
8.2.14. SEKISUI
8.2.15. THERMO
FISHER SCIENTIFIC
LIST
OF TABLES
TABLE 1: MARKET SNAPSHOT -
MEDICAL ENZYMES
TABLE 2: MEDICAL APPLICATION
OF VARIOUS ENZYMES
TABLE 3: APPLICATIONS OF
ENZYMES IN PHARMACEUTICALS INDUSTRY
TABLE 4: REGULATORY
FRAMEWORK
TABLE 5: EUROPE MEDICAL
ENZYMES MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 6: EUROPE MEDICAL
ENZYMES MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 7: EUROPE MEDICAL
ENZYMES MARKET, BY HYDROLASE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 8: EUROPE MEDICAL
ENZYMES MARKET, BY HYDROLASE ENZYME, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 9: EUROPE MEDICAL
ENZYMES MARKET, BY THROMBOLYTIC ENZYME, HISTORICAL YEARS, 2018-2021 (IN $
MILLION)
TABLE 10: EUROPE MEDICAL
ENZYMES MARKET, BY THROMBOLYTIC ENZYME, FORECAST YEARS, 2022-2030 (IN $
MILLION)
TABLE 11: EUROPE MEDICAL
ENZYMES MARKET, BY DIGESTIVE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 12: EUROPE MEDICAL
ENZYMES MARKET, BY DIGESTIVE ENZYME, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 13: EUROPE MEDICAL
ENZYMES MARKET, BY ENDONUCLEASE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $
MILLION)
TABLE 14: EUROPE MEDICAL
ENZYMES MARKET, BY ENDONUCLEASE ENZYME, FORECAST YEARS, 2022-2030 (IN $
MILLION)
TABLE 15: EUROPE MEDICAL
ENZYMES MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 16: EUROPE MEDICAL
ENZYMES MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 17: EUROPE MEDICAL
ENZYMES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 18: EUROPE MEDICAL
ENZYMES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 19: LEADING PLAYERS
OPERATING IN EUROPE MEDICAL ENZYMES MARKET
TABLE 20: LIST OF MERGERS
& ACQUISITIONS
TABLE 21: LIST OF PRODUCT LAUNCHES
& DEVELOPMENTS
TABLE 22: LIST OF
PARTNERSHIPS & AGREEMENTS
TABLE 23: LIST OF BUSINESS
EXPANSIONS & DIVESTITURES
LIST
OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE
FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: VALUE CHAIN
ANALYSIS
FIGURE 6: KEY BUYING
CRITERIA
FIGURE 7: EUROPE MEDICAL
ENZYMES MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021
FIGURE 8: EUROPE MEDICAL
ENZYMES MARKET, BY HYDROLASE, 2022-2030 (IN $ MILLION)
FIGURE 9: EUROPE MEDICAL
ENZYMES MARKET, GROWTH POTENTIAL, BY HYDROLASE ENZYME, IN 2021
FIGURE 10: EUROPE MEDICAL
ENZYMES MARKET, BY HYALURONIDASE, 2022-2030 (IN $ MILLION)
FIGURE 11: EUROPE MEDICAL
ENZYMES MARKET, BY LYSOZYMES, 2022-2030 (IN $ MILLION)
FIGURE 12: EUROPE MEDICAL
ENZYMES MARKET, BY OTHER HYDROLASES ENZYMES, 2022-2030 (IN $ MILLION)
FIGURE 13: EUROPE MEDICAL
ENZYMES MARKET, BY THROMBOLYTIC ENZYMES, 2022-2030 (IN $ MILLION)
FIGURE 14: EUROPE MEDICAL
ENZYMES MARKET, GROWTH POTENTIAL, BY THROMBOLYTIC ENZYME, IN 2021
FIGURE 15: EUROPE MEDICAL
ENZYMES MARKET, BY STREPTOKINASE, 2022-2030 (IN $ MILLION)
FIGURE 16: EUROPE MEDICAL
ENZYMES MARKET, BY UROKINASE, 2022-2030 (IN $ MILLION)
FIGURE 17: EUROPE MEDICAL
ENZYMES MARKET, BY OTHER THROMBOLYTIC ENZYMES, 2022-2030 (IN $ MILLION)
FIGURE 18: EUROPE MEDICAL
ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2030 (IN $ MILLION)
FIGURE 19: EUROPE MEDICAL
ENZYMES MARKET, GROWTH POTENTIAL, BY DIGESTIVE ENZYME, IN 2021
FIGURE 20: EUROPE MEDICAL
ENZYMES MARKET, BY LACTASE, 2022-2030 (IN $ MILLION)
FIGURE 21: EUROPE MEDICAL
ENZYMES MARKET, BY L-ASPARAGINASE, 2022-2030 (IN $ MILLION)
FIGURE 22: EUROPE MEDICAL
ENZYMES MARKET, BY OTHER DIGESTIVE ENZYMES, 2022-2030 (IN $ MILLION)
FIGURE 23: EUROPE MEDICAL
ENZYMES MARKET, BY ENDONUCLEASE, 2022-2030 (IN $ MILLION)
FIGURE 24: EUROPE MEDICAL
ENZYMES MARKET, GROWTH POTENTIAL, BY ENDONUCLEASE, IN 2021
FIGURE 25: EUROPE MEDICAL
ENZYMES MARKET, BY BENZONASE, 2022-2030 (IN $ MILLION)
FIGURE 26: EUROPE MEDICAL
ENZYMES MARKET, BY OTHER ENDONUCLEASES, 2022-2030 (IN $ MILLION)
FIGURE 27: EUROPE MEDICAL
ENZYMES MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021
FIGURE 28: EUROPE MEDICAL
ENZYMES MARKET, BY DISEASE TREATMENT, 2022-2030 (IN $ MILLION)
FIGURE 29: EUROPE MEDICAL
ENZYMES MARKET, BY DIAGNOSTIC TOOLS, 2022-2030 (IN $ MILLION)
FIGURE 30: EUROPE MEDICAL
ENZYMES MARKET, BY BIOMEDICAL RESEARCH, 2022-2030 (IN $ MILLION)
FIGURE 31: EUROPE MEDICAL
ENZYMES MARKET, BY OTHER APPLICATIONS, 2022-2030 (IN $ MILLION)
FIGURE 32: EUROPE MEDICAL
ENZYMES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 33: UNITED KINGDOM
MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 34: GERMANY MEDICAL
ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 35: FRANCE MEDICAL
ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 36: ITALY MEDICAL
ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 37: BELGIUM MEDICAL
ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 38: POLAND MEDICAL
ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 39: REST OF EUROPE
MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
KEY
FINDINGS
The Europe medical enzymes
market is evaluated to grow with a CAGR of 5.86% during the forecasted period
of 2022 to 2030. Key factors strengthening the regional market’s growth are the
increasing demand for enzymes in the pharmaceutical sector, the rise in
research and development activities, and the growing need for nutraceuticals
and dietary supplements following the COVID-19 pandemic.
Get more Insights into the Europe
Medical Enzymes Market:
https://inkwoodresearch.com/reports/europe-medical-enzymes-market/
MARKET
INSIGHTS
The
Europe medical enzymes market growth evaluation encompasses a detailed
assessment of the United Kingdom, Poland, Belgium, Germany, France, Italy, and
Rest of Europe. According to industry estimates, France spent more than 11% of
its gross domestic product (GDP) on healthcare. Moreover, according to the
Organisation for Economic Co-operation and
Development (OECD), cancer was the leading cause of death in the country, accounting
for 28.5% of all fatalities in 2014, followed by cardiovascular diseases. In
this regard, the rise in alcohol and tobacco consumption is the major cause of
diseases in France. As a result, the application of enzymes for treating
various conditions and diseases is a key driver of the market’s growth in the
country.
On
the other hand, Italy is one of the first countries to introduce advanced
therapies into the European market. With the increase in research in advanced
therapies as well as diagnosis, the Italian biotech industry is experiencing rapid
expansion. Moreover, investments in research and vaccines have increased in the
country, as well. Therefore, the aforementioned factors are expected to propel
the Europe medical enzymes market growth over the forecasting years.
COMPETITIVE
INSIGHTS
Eminent firms operating in
the market include BBI Solutions, Sanofi, BASF, etc.
Our report offerings
include:
· Explore
key findings of the overall market
· Strategic
breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
· Market
forecasts for a minimum of 9 years, along with 3
years of historical data for all segments, sub-segments, and regions
· Market
Segmentation cater to a thorough assessment of key
segments with their market estimations
· Geographical
Analysis: Assessments of the mentioned regions and country-level segments with their market share
· Key
analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix,
Key Buying Criteria, etc.
· Competitive
landscape is the theoretical explanation of the key companies based on factors,
market share, etc.
· Company
profiling: A detailed company overview, product/services offered, SCOT
analysis, and recent strategic developments
SEGMENTATION
1. ADVANCED
ENZYMES
2. AMANO
ENZYME
3. BASF
4. BBI
SOLUTIONS
5. BRAIN
6. CODEXIS
7. CPC
BIOTECH
8. DSM
9. DUPONT
10. NOVOZYMES
11. NOVUS
12. ROCHE
13. SANOFI
14. SEKISUI
15. THERMO
FISHER SCIENTIFIC
Comments
Post a Comment